Last updated on September 2018

A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)

Brief description of study

The purpose of this study is to assess the safety and efficacy of INCB050465 in subjects with relapsed or refractory diffuse large B-cell lymphoma.

Clinical Study Identifier: NCT02998476

Contact Investigators or Research Sites near you

Start Over

Incyte Corporation Call Center

Sutter Gould Medical Foundation
Modesto, CA United States